诺诚健华:诺诚健华医药有限公司2023年第一次临时股东大会(股东特别大会)会议资料2023-08-16
InnoCare Pharma Limited
9969
(1)
(2)
8 8 EGM-1 EGM-3
( www.hkexnews.hk) ( www.innocarepharma.com)
48
183
17 1712-1716
.......................................... 1
.......................................................... 2
..................................................... 10
1. ................................................. 10
2. .............................. 12
3. ......................................... 21
4. .................................. 22
5. ............................................. 22
6. ............................................. 22
7. ............................................. 22
........................... I-1
............................................... EGM-1
–i–
( www.hkexnews.hk) ( www.innocarepharma.com)
48
183 17 1712-1716
183 17 1712-1716
(852) 2862 8555
(852) 2865 0990
www.computershare.com/hk/contact
( www.hkexnews.hk)
( www.sse.com.cn) ( www.innocarepharma.com)
–1–
–2–
9969
688428
17
(i) (ii)
–3–
5.
1.
–4–
0.000002
XIVA
1.
;
51,481,607
2.92%
–5–
51,481,607
–6–
(i)
(ii)
571
0.000002
622 15
–7–
1.
Summit
Lakeview
TMF (Cayman) Ltd.
51,481,607
2.92%
–8–
%
–9–
InnoCare Pharma Limited
9969
Ogier Global (Cayman) Limited
89 Nexus Way, Camana Bay
Grand Cayman, KY1-9009
Cayman Islands
8 8
248
40
(1)
(2)
1.
(i)
(ii)
– 10 –
(i)
(ii)
(iii)
(1) (2)
(1) (2)
– 11 –
2.
(i)
(ii)
(iii)
(iv)
(v)
(i)
(ii)
– 12 –
(i) (ii)
(iii)
(i)
(ii)
(iii)
(iv)
(v)
(vi)
– 13 –
(a)
(b)
– 14 –
– 15 –
(i)
(ii)
(iii)
(iv)
(v)
– 16 –
5.
5.
12
5.
092-2022
10
(i) (12)
(ii)
(iii)
(iv)
– 17 –
(i)
(ii)
(i)
(ii)
11.
– 18 –
1,764,321,452
51,481,607
51,481,607
2.92%
(12)
(1)
17.03D(1)
– 19 –
0.1%
(i)
(ii)
(iii)
0.1%
(i)
(ii)
– 20 –
(i)
(ii)
3.
(1)
(2)
8 8
EGM-1 EGM-3
http://www.hkexnews.hk
( www.innocarepharma.com)
– 21 –
4.
183 17 1712-1716
5.
EGM-1 EGM-3
6.
14
7.
– 22 –
1.
(i)
(ii)
(iii) (iv)
(v)
10
– I-1 –
28
(a) (b)
(i)
(ii) (iii)
– I-2 –
2.
(i)
(ii)
3.
51,481,607
2.92%
0.1%
3.43% 60,430,357 (i)
(ii)
2.92% 51,481,607 0.51%
8,948,750
3.43% 60,430,357
(3)
17.03C(1)(b)
4.
– I-3 –
(12)
(1)
17.03D(1)
12
0.1%
0.1%
(i) (ii)
0.1% 12
0.1%
– I-4 –
5.
(i)
(a)
(b)
(c)
(ii)
(iii)
(iv)
– I-5 –
(i) (ii)
(i) (ii)
12
(i)
(ii)
– I-6 –
(iii)
(iv) 12
12
12
(v) 12
12
6.
(a)
(b)
– I-7 –
7.
8.
(a) (b)
9.
(i) 13.09
XIVA
– I-8 –
(ii)
(iii) 60 30
(i)
(ii)
(iv)
30
10.
11.
(i)
– I-9 –
(ii)
(iii)
(iv)
(v)
(vi)
(i) (ii)
(iii)
(iv)
– I-10 –
12.
(i)
(ii)
(i)
(ii)
a.
Q=Q0 × (1 + n)
Q0 n
Q
b.
Q=Q0 × P1 × (1 + n) ÷ (P1 + P2 × n)
Q0 P1
P2 n
Q
c.
Q=Q0 × n
Q0 n
n Q
– I-11 –
a.
P=P0 ÷ (1 + n)
P0 n
P
b.
P=P0 × (P1 + P2 × n) ÷[P1 × (1 + n)]
P0 P1 P2 n
P
c.
P=P0 ÷ n
P0 n P
13.
– I-12 –
14.
(i)
(ii)
(i) (5)
(ii)
(iii)
(iv)
(v)
(5) (10)
(5)
17.03
– I-13 –
15.
(i)
(ii)
21
– I-14 –
InnoCare Pharma Limited
9969
8 8
1. 51,481,607
(a)
(b)
– EGM-1 –
(c)
(d)
2. 1
– EGM-2 –
1.
2.
3.
183 17 1712-1716
4.
5.
6.
(48) 183 17
1712-1716
7.
8.
9.
www.innocarepharma.com www.hkexnews.hk
www.sse.com.cn
10.
– EGM-3 –